The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives
Related Experiment Video
Updated: Oct 18, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
D G Smith1, A D Gribble, D Haigh
1SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex, UK. Dave_G_Smith@sbphrd.com
Abstract:
Aryl hydroxylamine derivatives have been synthesised that are some of the most potent inhibitors of hCMV protease prepared to date (IC50 14-60 nM). Mass spectrometry studies indicate that oxazinone derived hydroxylamines inhibit the enzyme by acylation of Ser132 whereas non-oxazinone derived hydroxylamines appear to inhibit via formation of a sulfinanilide at Cys138.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Cytomegalovirus Disease
Enzyme Inhibition
